SkinBioTherapeutics (UK) Market Value
| SBTX Stock | 16.00 0.12 0.76% |
| Symbol | SkinBioTherapeutics |
SkinBioTherapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to SkinBioTherapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of SkinBioTherapeutics.
| 10/25/2024 |
| 11/24/2024 |
If you would invest 0.00 in SkinBioTherapeutics on October 25, 2024 and sell it all today you would earn a total of 0.00 from holding SkinBioTherapeutics PLC or generate 0.0% return on investment in SkinBioTherapeutics over 30 days. SkinBioTherapeutics is related to or competes with Zegona Communications, Spirent Communications, Aeorema Communications, Cars, Inspiration Healthcare, MyHealthChecked Plc, and Target Healthcare. SkinBioTherapeutics is entity of United Kingdom More
SkinBioTherapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure SkinBioTherapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess SkinBioTherapeutics PLC upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.41 | |||
| Information Ratio | 0.0895 | |||
| Maximum Drawdown | 21.17 | |||
| Value At Risk | (5.94) | |||
| Potential Upside | 9.68 |
SkinBioTherapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for SkinBioTherapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as SkinBioTherapeutics' standard deviation. In reality, there are many statistical measures that can use SkinBioTherapeutics historical prices to predict the future SkinBioTherapeutics' volatility.| Risk Adjusted Performance | 0.0992 | |||
| Jensen Alpha | 0.4776 | |||
| Total Risk Alpha | (0.19) | |||
| Sortino Ratio | 0.0916 | |||
| Treynor Ratio | 1.35 |
SkinBioTherapeutics PLC Backtested Returns
SkinBioTherapeutics appears to be somewhat reliable, given 3 months investment horizon. SkinBioTherapeutics PLC owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.11, which indicates the firm had a 0.11% return per unit of risk over the last 3 months. By inspecting SkinBioTherapeutics' technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please review SkinBioTherapeutics' Coefficient Of Variation of 843.71, semi deviation of 3.27, and Risk Adjusted Performance of 0.0992 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, SkinBioTherapeutics holds a performance score of 8. The entity has a beta of 0.39, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, SkinBioTherapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding SkinBioTherapeutics is expected to be smaller as well. Please check SkinBioTherapeutics' total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether SkinBioTherapeutics' existing price patterns will revert.
Auto-correlation | -0.85 |
Excellent reverse predictability
SkinBioTherapeutics PLC has excellent reverse predictability. Overlapping area represents the amount of predictability between SkinBioTherapeutics time series from 25th of October 2024 to 9th of November 2024 and 9th of November 2024 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of SkinBioTherapeutics PLC price movement. The serial correlation of -0.85 indicates that around 85.0% of current SkinBioTherapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.85 | |
| Spearman Rank Test | -0.33 | |
| Residual Average | 0.0 | |
| Price Variance | 1.05 |
SkinBioTherapeutics PLC lagged returns against current returns
Autocorrelation, which is SkinBioTherapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting SkinBioTherapeutics' stock expected returns. We can calculate the autocorrelation of SkinBioTherapeutics returns to help us make a trade decision. For example, suppose you find that SkinBioTherapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
SkinBioTherapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If SkinBioTherapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if SkinBioTherapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in SkinBioTherapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
SkinBioTherapeutics Lagged Returns
When evaluating SkinBioTherapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of SkinBioTherapeutics stock have on its future price. SkinBioTherapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, SkinBioTherapeutics autocorrelation shows the relationship between SkinBioTherapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in SkinBioTherapeutics PLC.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for SkinBioTherapeutics Stock Analysis
When running SkinBioTherapeutics' price analysis, check to measure SkinBioTherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SkinBioTherapeutics is operating at the current time. Most of SkinBioTherapeutics' value examination focuses on studying past and present price action to predict the probability of SkinBioTherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SkinBioTherapeutics' price. Additionally, you may evaluate how the addition of SkinBioTherapeutics to your portfolios can decrease your overall portfolio volatility.